Literature DB >> 10601856

Structure and interaction of VacA of Helicobacter pylori with a lipid membrane.

C Pagliaccia1, X M Wang, F Tardy, J L Telford, J M Ruysschaert, V Cabiaux.   

Abstract

In its mature form, the VacA toxin of Helicobacter pylori is a 95-kDa protein which is released from the bacteria as a low-activity complex. This complex can be activated by low-pH treatment that parallels the activity of the toxin on target cells. VacA has been previously shown to insert itself into lipid membranes and to induce anion-selective channels in planar lipid bilayers. Binding of VacA to lipid vesicles and its ability to induce calcein release from these vesicles were systematically compared as a function of pH. These two phenomena show a different pH-dependence, suggesting that the association with the lipid membrane may be a two-step mechanism. The secondary and tertiary structure of VacA as a function of pH and the presence of lipid vesicles were investigated by Fourier-transform infrared spectroscopy. The secondary structure of VacA is identical whatever the pH and the presence of a lipid membrane, but the tertiary structure in the presence of a lipid membrane is dependent on pH, as evidenced by H/D exchange.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601856     DOI: 10.1046/j.1432-1327.2000.00970.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  How the loop and middle regions influence the properties of Helicobacter pylori VacA channels.

Authors:  F Tombola; C Pagliaccia; S Campello; J L Telford; C Montecucco; E Papini; M Zoratti
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization.

Authors:  M S McClain; P Cao; T L Cover
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin.

Authors:  Tasia M Pyburn; Nora J Foegeding; Christian González-Rivera; Nathan A McDonald; Kathleen L Gould; Timothy L Cover; Melanie D Ohi
Journal:  Mol Microbiol       Date:  2016-07-08       Impact factor: 3.501

Review 5.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 6.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

7.  Protein-lipid interaction at low pH induces oligomerization of the MakA cytotoxin from Vibrio cholerae.

Authors:  Aftab Nadeem; Bernt Eric Uhlin; Sun Nyunt Wai; Alexandra Berg; Hudson Pace; Athar Alam; Eric Toh; Jörgen Ådén; Nikola Zlatkov; Si Lhyam Myint; Karina Persson; Gerhard Gröbner; Anders Sjöstedt; Marta Bally; Jonas Barandun
Journal:  Elife       Date:  2022-02-08       Impact factor: 8.140

8.  Immunosuppressive and proinflammatory activities of the VacA toxin of Helicobacter pylori.

Authors:  Cesare Montecucco; Marina de Bernard
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

9.  The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms.

Authors:  Marianna Boncristiano; Silvia Rossi Paccani; Silvia Barone; Cristina Ulivieri; Laura Patrussi; Dag Ilver; Amedeo Amedei; Mario Milco D'Elios; John L Telford; Cosima T Baldari
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.

Authors:  Vijay R Gupta; Hetal K Patel; Sean S Kostolansky; Roberto A Ballivian; Joseph Eichberg; Steven R Blanke
Journal:  PLoS Pathog       Date:  2008-05-23       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.